Fenestrated endovascular repair of complex aortic aneurysms
| Autor: | C. Canning, Prakash Madhavan, M. McCafferty, Sean O’Neill, Zenia Martin, Mary Paula Colgan, S. N. Haider, O. Abdulrahim, J. Fitzpatrick |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Renal function Prosthesis Design Asymptomatic Endovascular aneurysm repair Blood Vessel Prosthesis Implantation Aneurysm medicine Humans cardiovascular diseases Aged Aged 80 and over medicine.diagnostic_test business.industry Endovascular Procedures Stent General Medicine Middle Aged medicine.disease Blood Vessel Prosthesis Creatinine rise Surgery Treatment Outcome Angiography Referral centre cardiovascular system Female Stents Radiology medicine.symptom business Ireland Aortic Aneurysm Abdominal Follow-Up Studies |
| Zdroj: | Irish Journal of Medical Science (1971 -). 184:249-255 |
| ISSN: | 1863-4362 0021-1265 |
| DOI: | 10.1007/s11845-014-1095-2 |
| Popis: | Fenestrated endovascular aneurysm repair (FEVAR) provides an endovascular solution for patients with large abdominal aortic aneurysms and challenging neck anatomy in addition to repair of endoleaks and pseudoaneurysms. This article reports the midterm outcomes of FEVAR from a single-tertiary referral centre in Ireland. From 2006 to 2012, nine consecutive asymptomatic patients with neck anatomy unfavourable for standard EVAR underwent endovascular repair with a customised fenestrated Zenith stent graft. An additional three patients had fenestrated grafts for repair of pseudoaneurysms (n = 2) following open AAA repair and a type I endoleak (n = 1). All patients were prospectively enrolled in a computerised database. Outcomes including mortality, morbidity, renal function, target vessel patency, endoleak and reintervention were analysed. The mean age and aneurysm size in the primary repair group were 74 years (65–84 years) and 6 cm (5–8.3 cm), respectively, and in the secondary repair group, the mean age was 66 years (61–75 years). No procedures required open conversion, and no visceral arteries were lost. On completion angiography, two patients in group 1 had a type I endoleak and one had a type III endoleak. There were no endoleaks in the secondary repair group. Follow-up ranged from 30 days to 6 years. There was one death within 30 days (8 %) and two deaths at 3 years from non-aneurysm-related causes. Six patients required secondary interventions. Three patients had a transient post-operative creatinine rise of >30 %. Our study supports FEVAR as a feasible and effective therapy in the management of patients with complex aortic aneurysms. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink